It is estimated that in the U.S. alone, 4% of the population older than 40 years old has Fuchs’ endothelial corneal dystrophy, one of the leading types of corneal endothelial disease.
Despite the prevalence of Fuchs’ endothelial corneal dystrophy in millions of people, each year fewer than 70,000 patients worldwide undergo endothelial keratoplasty procedures. While endothelial keratoplasty is effective in treating corneal endothelial disease, these are complex procedures that require access to corneal tissue, skilled corneal surgeons and an onerous recovery for patients. Globally,